The US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component ...

Zimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is highlighting ...

Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.

Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...

Knee pain can stem from many different causes, but it’s often linked to arthritis—an inflammation of the joint. This ...

March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings ... clearance of Persona ® Revision SoluTion™ Femur, a revision knee implant component offering an alternative for patients with ...

In addition, Zimmer Biomet is debuting ZBX™, its new ... a shorter surgical time compared to the cemented implant. The Oxford Partial Knee Is not indicated for use in the lateral compartment ...

The Smart Orthopedic Implants market is expected to grow from an estimated USD 26.21 Billion in 2024 to USD 40.66 Billion in ...

March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings ... clearance of Persona ® Revision SoluTionTM Femur, a revision knee implant component offering an alternative for patients with ...

A Revision Knee Implant Alternative for Patients with Metal Sensitivities WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology ...